Delivery Order SPE2DB22D3016-SPE2DB24FBFS1

Award Date 8/30/24
Potential Completion Date 9/3/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) autoinjector pens. The award, a Delivery Order valued at $42,560.00, has a firm fixed price and is not set aside for any specific business category. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, through its Corporate Office division, will deliver the Humira pens to support...
This federal contract award, with the ID SPE2DB24D2003|SPE2DB24FXGC3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,871.84 Firm Fixed Price delivery order is for the supply of HUMIRA PEN 40 MG/0.8 MLS, a prescription medication. The contract has an ultimate completion date of August 13, 2024. AmerisourceBergen, through its Corporate Office division, will provide the requested pharmaceutical product to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens. The $11,226.92 firm-fixed-price delivery order has a completion date of June 10, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,928.74 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This award is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $77,101.72 delivery order contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) prefilled pens. The award has a ceiling value of $24,079.84 and an ultimate completion date of September 17, 2024. The contract is a delivery order with a firm fixed-price pricing type, and there is no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA PEN 40 MG/0.8 MLS. The $26,520.17 firm fixed-price delivery order contract has an ultimate completion date of December 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $76,152.44 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB20D1109|SPE2DB23FP11R, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,277.54 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The contract has a completion date of May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FV54D, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,960.81 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBFS1
    Delivery Order

This federal contract award, SPE2DB22D3016|SPE2DB24FBFS1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) 80 mg/0.8 mL pens. The $21,033.74 firm-fixed-price delivery order contract has an ultimate completion date of September 3, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this contract to supply the Humira medication to support military treatment facilities and other government healthcare programs. The company has significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for providing a comprehensive range of pharmaceutical and medical products to federal agencies.

Generated 11/29/24, 9:02 AM